CLINICAL_TRIALS
trial_result
· 2026-02-27
Clinical Trial Update: The Effects of Dupilumab on Allergic Contact Dermatitis [Phase 4]
Summary
Phase 4 trial evaluating dupilumab for allergic contact dermatitis with results posted in 2026. The study is currently not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Allergic Contact Dermatitis | Phase 4 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-27